AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUL 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The bacille Calmette-Guerin (BCG) tuberculosis vaccine may improve immunity against other infections as well, researchers say.
Results from other studies indicated that the BCG vaccine "may have a non-specific beneficial effect on childhood survival in areas with high mortality," explained May-Lill Garly and colleagues at the Projecto de Saude de Bandim in Bissau, Guinea-Bissau, the Medical Research Council Laboratories in Banjul, Gambia, and the Statens Serum Institute in Copenhagen, Denmark.
Garly and coauthors found that BCG-vaccinated children in a high-mortality area had a significantly lower risk of death and that this effect was independent of tuberculosis protection.
Among children participating in a measles vaccine study, those with a BCG scar had a mortality rate less than half that of the counterparts, the researchers said. Moreover, BCG-vaccinated children with hypersensitivity reactions to tuberculin had a mortality rate less than half that of immunized children without such reactions.
Excluding children with tuberculosis exposure did not significantly affect the impact of BCG scar or tuberculin positivity on mortality risk, study data showed. The exclusion of dead HIV-seropositive children also left the mortality ratio unchanged.
...